Cell Source, Inc. SEC filings CLCS
Cell Source, Inc. has 139 filings in SEC EDGAR's recent list, going back to Mar 5, 2013. Its latest annual report, Form 10-K, was filed on Apr 7, 2026 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Jun 27, 2025 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2025 |
| 10-K | Annual report | Apr 7, 2026 | Dec 31, 2024 |
| 15-12G | Deregistration | Jul 16, 2025 | — |
| 8-K |
Current report
Auditor change
|
Jun 27, 2025 | Jun 26, 2025 |
| NT 10-K | Filing | Mar 28, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 19, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | Jul 29, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Jun 24, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Apr 9, 2024 | Mar 22, 2024 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| D | Filing | Oct 6, 2023 | — |
| 10-Q | Quarterly report | Sep 19, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | Aug 23, 2023 | Mar 31, 2023 |
| NT 10-Q | Filing | Aug 15, 2023 | Jun 30, 2023 |
| 10-K | Annual report | Aug 8, 2023 | Dec 31, 2022 |
| NT 10-Q | Filing | May 16, 2023 | Mar 31, 2023 |
| NT 10-K | Filing | Mar 31, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Dec 8, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Dec 2, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | Nov 2, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 21, 2022 | Jul 18, 2022 |
| NT 10-Q | Filing | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Officer or director change
|
May 6, 2022 | May 6, 2022 |
| 10-K | Annual report | Apr 15, 2022 | Dec 31, 2021 |
| NT 10-K | Filing | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Mar 11, 2022 | Mar 10, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Apr 15, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2021 | Mar 25, 2021 |
| NT 10-K | Filing | Mar 31, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Nov 13, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 15, 2020 | Mar 31, 2020 |
| 10-K | Annual report | Mar 30, 2020 | Dec 31, 2019 |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| D | Filing | Oct 18, 2019 | — |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| 10-K/A | Amended annual report | Jun 19, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | May 20, 2019 | Mar 31, 2019 |
| NT 10-Q | Filing | May 15, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Officer or director change
|
Apr 19, 2019 | Apr 19, 2019 |
| 10-K | Annual report | Apr 1, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Nov 14, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Oct 18, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | Oct 18, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Jul 25, 2018 | Sep 30, 2017 |
| 10-Q | Quarterly report | Jul 25, 2018 | Jun 30, 2017 |
| 10-Q | Quarterly report | Jul 25, 2018 | Mar 31, 2017 |
| 10-K | Annual report | Jul 25, 2018 | Dec 31, 2017 |
| NT 10-K | Filing | Mar 31, 2017 | Dec 31, 2016 |
| 10-Q | Quarterly report | Nov 18, 2016 | Sep 30, 2016 |
| NT 10-Q | Filing | Nov 15, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 15, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 13, 2016 | Mar 31, 2016 |
| 10-K | Annual report | Apr 14, 2016 | Dec 31, 2015 |
| NT 10-K | Filing | Mar 31, 2016 | Dec 31, 2015 |
| 10-Q | Quarterly report | Nov 16, 2015 | Sep 30, 2015 |
| 8-K |
Current report
Other events
|
Nov 16, 2015 | Nov 14, 2015 |
| D | Filing | Nov 13, 2015 | — |
| 8-K |
Current report
Other events
|
Nov 5, 2015 | Nov 4, 2015 |
| 8-K |
Current report
Officer or director change
|
Aug 19, 2015 | Aug 19, 2015 |
| 10-Q | Quarterly report | Aug 11, 2015 | Jun 30, 2015 |
| D | Filing | Jul 28, 2015 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 28, 2015 | Jul 20, 2015 |
| 8-K |
Current report
Material agreement
|
Jun 10, 2015 | Jun 4, 2015 |
| D | Filing | Jun 3, 2015 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 3, 2015 | May 15, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
May 28, 2015 | May 28, 2015 |
| 10-Q | Quarterly report | May 13, 2015 | Mar 31, 2015 |
| 8-A12G | Form 8-a12g | Apr 1, 2015 | — |
| 8-K |
Current report
New debt, Unregistered share sale
|
Apr 1, 2015 | Mar 26, 2015 |
| 10-K | Annual report | Mar 13, 2015 | Dec 31, 2014 |
| 8-K |
Current report
New debt
|
Dec 2, 2014 | Nov 26, 2014 |
| 10-Q | Quarterly report | Nov 14, 2014 | Sep 30, 2014 |
| 424B3 | Prospectus | Nov 12, 2014 | — |
| EFFECT | Filing | Nov 10, 2014 | — |
| CORRESP | Letter to the SEC | Nov 7, 2014 | — |
| CORRESP | Letter to the SEC | Oct 24, 2014 | — |
| S-1/A | Amended registration statement | Oct 24, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 9, 2014 | — |
| S-1/A | Amended registration statement | Sep 23, 2014 | — |
| CORRESP | Letter to the SEC | Sep 23, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2014 | — |
| 10-Q | Quarterly report | Aug 19, 2014 | Jun 30, 2014 |
| NT 10-Q | Filing | Aug 15, 2014 | Jun 30, 2014 |
| S-1 | Registration statement | Aug 8, 2014 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Auditor change, Change in control, Officer or director change, Shareholder vote results
|
Jul 1, 2014 | Jun 30, 2014 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 30, 2014 | Jun 27, 2014 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 26, 2014 | Jun 23, 2014 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 6, 2014 | May 7, 2014 |
| 10-Q | Quarterly report | Apr 25, 2014 | Mar 31, 2014 |
| 10-K | Annual report | Mar 25, 2014 | Dec 31, 2013 |
| 10-Q | Quarterly report | Nov 12, 2013 | Sep 30, 2013 |
| 424B2 | Prospectus | Sep 18, 2013 | — |
| EFFECT | Filing | Sep 17, 2013 | — |
| CORRESP | Letter to the SEC | Sep 13, 2013 | — |
| CORRESP | Letter to the SEC | Sep 6, 2013 | — |
| S-1/A | Amended registration statement | Sep 6, 2013 | — |
| CORRESP | Letter to the SEC | Aug 26, 2013 | — |
| S-1/A | Amended registration statement | Aug 20, 2013 | — |
| CORRESP | Letter to the SEC | Aug 13, 2013 | — |
| S-1/A | Amended registration statement | Aug 6, 2013 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2013 | — |
| S-1/A | Amended registration statement | Jul 15, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2013 | — |
| S-1/A | Amended registration statement | Jun 10, 2013 | — |
| UPLOAD | Letter from the SEC | May 23, 2013 | — |
| S-1/A | Amended registration statement | May 10, 2013 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2013 | — |
| S-1 | Registration statement | Mar 5, 2013 | — |
Showing 115 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CLCS (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1569340
- Former names
- TICKET TO SEE, INC. (until Jun 26, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.